The Extraordinary Shareholders' Meeting
BIOHIT PLC. PRESS RELEASE 14.6.1999 11:45 A.M. 1 (1)
The Extraordinary Shareholders' Meeting of Biohit Plc. decided on June
13, 1999 to carry out a share issue targeted to international and
Finnish institutional investors and the Finnish public.
Deviating from the terms of the share issue described in the Offering
Circular the Extraordinary Shareholders' Meeting decided to issue
2.000.000 new B-shares of Biohit Plc., instead of 4.000.000, for a
nominal value of EUR 0,17 each. All shares will be offered to
international and Finnish institutional investors and the Finnish
public. The Board of Directors of Biohit Plc. will make a decision
concerning the distribution of the shares between institutional
investors and the public. After the issue the number of B-shares will
be 8.389.037 pieces and the total number of A- and B-shares 12.264.537
pieces.
The Extraordinary Shareholders' Meeting decided that the subscription
price for the shares is EUR 4,5 each.
Subscriptions of the shares during the subscription period have been
made actively. The subscription period continues until June 15, 1999.
In any situation of oversubscription the issue may be discontinued,
but in the case of the public subscription, however, at earliest on
June 14 at 4:30 p.m. Since the Extraordinary Shareholders' Meeting
decided to change the amount of shares issued it is possible to cancel
a subscription made in the public issue before June 11, 1999 still on
June 15, 1999. Subscriptions for the issue are received at trust
offices of Merita pankki Plc., at Merita Customer Service, tel. 0800-
123 123 (in Finnish), tel. 0800-122 122 (in Swedish) and at the Solo
Bank at internet. The subscriptions may be cancelled at the places of
subscription.
The Board of Directors of Biohit Plc. have today submitted a listing
application to Helsinki Exchanges in order to seek listing for the B-
shares of the Company at the NM-list of Helsinki Exchanges. The
trading of the B-shares is expected to commence on June 18, 1999 on
the condition that Helsinki Exchanges accept the application.
Biohit Plc.
Further information: Osmo Suovaniemi, President, tel: 09-773 861, fax:
773 86 205
Distribution: Helsinki Exchanges
Press